265 related articles for article (PubMed ID: 14657819)
1. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial.
Klenner AF; Fusch C; Rakow A; Kadow I; Beyersdorff E; Eichler P; Wander K; Lietz T; Greinacher A
J Pediatr; 2003 Dec; 143(6):741-5. PubMed ID: 14657819
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
de Neef M; Heijboer H; van Woensel JB; de Haan RJ
Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
[TBL] [Abstract][Full Text] [Related]
4. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery.
Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM
Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study.
Arnts IJ; Heijnen JA; Wilbers HT; van der Wilt GJ; Groenewoud JM; Liem KD
J Adv Nurs; 2011 Dec; 67(12):2677-85. PubMed ID: 21722168
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial for maintaining peripheral intravenous lock in children.
Mok E; Kwong TK; Chan MF
Int J Nurs Pract; 2007 Feb; 13(1):33-45. PubMed ID: 17244243
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome.
Kuitunen A; Suojaranta-Ylinen R; Raivio P; Kukkonen S; Lassila R
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):18-22. PubMed ID: 17289474
[TBL] [Abstract][Full Text] [Related]
9. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
11. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
Gettings EM; Brush KA; Van Cott EM; Hurford WE
Crit Care; 2006; 10(6):R161. PubMed ID: 17109753
[TBL] [Abstract][Full Text] [Related]
12. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
[No Abstract] [Full Text] [Related]
13. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
[TBL] [Abstract][Full Text] [Related]
14. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
Menajovsky LB
Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
[TBL] [Abstract][Full Text] [Related]
16. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia: recent experience in a large teaching hospital.
Sturtevant JM; Pillans PI; Mackenzie F; Gibbs HH
Intern Med J; 2006 Jul; 36(7):431-6. PubMed ID: 16780449
[TBL] [Abstract][Full Text] [Related]
19. Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia.
Fretschner R; Dietrich K; Unertl K; Greinacher A
Transpl Int; 2005 Jun; 18(6):664-7. PubMed ID: 15910290
[TBL] [Abstract][Full Text] [Related]
20. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
